Shanghai Pharmaceutical Holding Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$17,391
Revenue Growth (%)14.45%
Net Income (US$ Millions)$460
Earnings Per Share (US$)$0.17
EPS Growth Rate (%)11.10%
Profit Margin2.65%
Total Equity (US$ Millions)$4,554
Return on Equity (%)10.68%
Long Term Debt (US$ Millions)$121
Debt To Equity Ratio (%)0.03%
Total Assets (US$ Millions)$11,916
Current Assets (US$ Millions)$8,679
Current Liabilities (US$ Millions)$5,921
Cost of Goods Sold (US$ Millions)$15,341
Inventory Turnover6.76